Trump order on drug pricing appears to issue subtle threat to pharma

Trump order on drug pricing appears to issue subtle threat to pharma

The order empowers the FDA to withdraw approvals if prices aren't lowered, a step experts say would be illegal.

Richard Epstein Slams Trump’s Drug Pricing Plan as “Ignorant,” Warns of Consequences for Innovation and Patient Access

President Trump’s bold new plan to slash prescription drug prices is drawing fire from one of the nation’s most prominent legal and economic scholars. University of Chicago law professor Richard Epstein criticized the executive order—which would impose a “most favored nation” (MFN) pricing rule on pharmaceuticals sold in the U.S.—as deeply flawed and likely to backfire. The executive order, unveiled during a press conference flanked by RFK Jr. …

Pharma faces 30-day deadline under Trump’s pricing order

US President Donald Trump has signed an executive order telling drugmakers to cut prices to 'most favoured nation' pricing.The post Pharma faces 30-day deadline under Trump’s pricing order appeared first on Clinical Trials Arena.